Department of Microbiology, Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, Ottawa, ON, Canada K1A 0R6, Department of Microbiology, Monash University, Building 76, Melbourne, Australia
Pasteurella multocida is an important veterinary pathogen that produces a wide range of lipopolysaccharide (LPS) structures, many of which mimic host glycoproteins. In this study, we complete our analysis of the LPS produced by the P. multocida Heddleston serovars by reporting the LPS structure and the LPS outer core biosynthesis loci of the type strains representing Heddleston serovars 6, 7 and 16. Genetic analysis revealed that the type strains representing serovars 6 and 7 share the same LPS outer core biosynthesis locus which we have designated LPS genotype L4. Comparative bioinformatic analysis revealed that although the serovar 16 type strain contained a different LPS locus, L8, there was a significant degree of nucleotide identity between the L4 and L8 loci. Structural analysis revealed that the LPS glycoforms produced by the L4 and L8 strains all contained the highly conserved inner core produced by all other P. multocida strains examined to date. The residues within the LPS outer core produced by the L4 and L8 strains were either Gal or derivatives of Gal; unlike all other P. multocida Heddleston type strains examined there are no heptosyltransferases encoded in the L4 and L8 outer core biosynthesis loci. The structure of the L4 LPS outer core produced by the serovar 6 type strain consisted of β-Gal-(1-3)-β-N-acetylgalactosamine (GalNAc)-(1-4)-β-GalNAc3OAc-(1-4)-α-GalNAc3OAc-(1-3)-β-Gal, whereas the serovar 7 type strain produced a highly truncated LPS outer core containing only a single β-Gal residue. The structure of the L8 LPS outer core produced by the serovar 16 type strain consisted of β-Gal-(1-3)-β-GalNAc-(1-4)-(α-GalNAc-(1-3)-)-α-GalNAc.
13C NMR, 1H NMR, methylation, GLC-MS, PCR, DNA sequencing, de-O-acylation, sugar analysis, 31P NMR, GLC, MS/MS, CE-ESI-MS, bioinformatic analysis
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6 C7
5,3,2 aXLDmanHepp 102.9 71.7 71.9 67.6 72.7 70.5 64.5
5,3,3,0 %xXEtN 63.1 41.3
5,3,3 P
5,3 aXLDmanHepp 100.7 79.3 76.3 66.2 73.3 70.5 64.5
5,4,4,3,3,2 Ac ? 23.4
5,4,4,3,3 aDGalpN 94.5 50.7 69.6 69.7 72.6 62.6
5,4,4,3,2 Ac ? 23.4
5,4,4,3,4,4 bDGalp 105.6 72.7 74.0 69.9 76.1 62.2
5,4,4,3,4 bDGalp 104.5 72.7 74.2 78.2 75.7 61.9
5,4,4,3 aDGalpN 95.3 49.3 72.5 72.3 71.9 61.9
5,4,4 bDGalp 104.0 70.9 77.7 65.8 76.0 62.2
5,4 bDGlcp 103.8 74.4 76.1 79.2 76.1 60.5
5,6 aDGlcp 102.7 73.3 74.2 69.9 72.7 60.9
5 aXLDmanHepp 97.6 71.6 74.9 75.1 72.7 80.3 63.2
4,0,0 xXEtN
4,0 %xXP?
4 P
aXKdop
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6 H7
5,3,2 aXLDmanHepp 5.11 3.97 3.90 3.81 3.81 4.04 3.75-3.75
5,3,3,0 %xXEtN 4.19 3.31
5,3,3 P
5,3 aXLDmanHepp 5.62 4.56 4.36 4.03 3.63 4.04 3.75-3.75
5,4,4,3,3,2 Ac - 2.08
5,4,4,3,3 aDGalpN 5.22 4.34 3.69 4.03 3.89 3.79-3.79
5,4,4,3,2 Ac - 2.08
5,4,4,3,4,4 bDGalp 4.61 3.62 3.68 3.92 3.70 3.78-3.78
5,4,4,3,4 bDGalp 4.43 3.73 3.71 4.19 3.63 3.81-3.81
5,4,4,3 aDGalpN 5.13 4.62 4.20 4.55 4.25 3.75-3.84
5,4,4 bDGalp 4.58 3.62 3.82 4.18 3.71 3.78-3.78
5,4 bDGlcp 4.71 3.51 3.62 3.75 3.68 3.95-4.01
5,6 aDGlcp 5.21 3.59 3.82 3.56 3.92 3.82-3.93
5 aXLDmanHepp 5.03 4.00 3.91 4.22 3.64 4.20 3.70-3.88
4,0,0 xXEtN
4,0 %xXP?
4 P
aXKdop
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6 C7/H7
5,3,2 aXLDmanHepp 102.9/5.11 71.7/3.97 71.9/3.90 67.6/3.81 72.7/3.81 70.5/4.04 64.5/3.75-3.75
5,3,3,0 %xXEtN 63.1/4.19 41.3/3.31
5,3,3 P
5,3 aXLDmanHepp 100.7/5.62 79.3/4.56 76.3/4.36 66.2/4.03 73.3/3.63 70.5/4.04 64.5/3.75-3.75
5,4,4,3,3,2 Ac 23.4/2.08
5,4,4,3,3 aDGalpN 94.5/5.22 50.7/4.34 69.6/3.69 69.7/4.03 72.6/3.89 62.6/3.79-3.79
5,4,4,3,2 Ac 23.4/2.08
5,4,4,3,4,4 bDGalp 105.6/4.61 72.7/3.62 74.0/3.68 69.9/3.92 76.1/3.70 62.2/3.78-3.78
5,4,4,3,4 bDGalp 104.5/4.43 72.7/3.73 74.2/3.71 78.2/4.19 75.7/3.63 61.9/3.81-3.81
5,4,4,3 aDGalpN 95.3/5.13 49.3/4.62 72.5/4.20 72.3/4.55 71.9/4.25 61.9/3.75-3.84
5,4,4 bDGalp 104.0/4.58 70.9/3.62 77.7/3.82 65.8/4.18 76.0/3.71 62.2/3.78-3.78
5,4 bDGlcp 103.8/4.71 74.4/3.51 76.1/3.62 79.2/3.75 76.1/3.68 60.5/3.95-4.01
5,6 aDGlcp 102.7/5.21 73.3/3.59 74.2/3.82 69.9/3.56 72.7/3.92 60.9/3.82-3.93
5 aXLDmanHepp 97.6/5.03 71.6/4.00 74.9/3.91 75.1/4.22 72.7/3.64 80.3/4.20 63.2/3.70-3.88
4,0,0 xXEtN
4,0 %xXP?
4 P
aXKdop